Photobiomodulation therapy protects skeletal muscle and improves muscular function of mdx mice in a dose-dependent manner through modulation of dystrophin

Nenhuma Miniatura disponível
Data
2018
Autores
Albuquerque-Pontes, Gianna Moes
Casalechi, Heliodora Leao
Tomazoni, Shaiane Silva
Serra, Andrey Jorge
Ferreira, Cheila de Sousa Bacelar
Brito, Rodrigo Barbosa de Oliveira
Melo, Brunno Lemes de [UNIFESP]
Vanin, Adriane Aver
Monteiro, Kadma Karenina Damasceno Soares
Delle, Humberto
Orientadores
Tipo
Artigo
Título da Revista
ISSN da Revista
Título de Volume
Resumo
This study aimed to analyze the protective effects of photobiomodulation therapy (PBMT) with combination of low-level laser therapy (LLLT) and light emitting diode therapy (LEDT) on skeletal muscle tissue to delay dystrophy progression in mdx mice (DMD (mdx) ). To this aim, mice were randomly divided into five different experimental groups: wild type (WT), placebo-control (DMD (mdx) ), PBMT with doses of 1 J (DMD (mdx) ), 3 J (DMD (mdx) ), and 10 J (DMD (mdx) ). PBMT was performed employing a cluster probe with 9 diodes (1 x 905nm super-pulsed laser diode
4 x 875nm infrared LEDs
and 4 x 640nm red LEDs, manufactured by Multi Radiance MedicalA (R), Solon - OH, USA), 3 times a week for 14 weeks. PBMT was applied on a single point (tibialis anterior muscle-bilaterally). We analyzed functional performance, muscle morphology, and gene and protein expression of dystrophin. PBMT with a 10 J dose significantly improved (p < 0.001) functional performance compared to all other experimental groups. Muscle morphology was improved by all PBMT doses, with better outcomes with the 3 and 10 J doses. Gene expression of dystrophin was significantly increased with 3 J (p < 0.01) and 10 J (p < 0.01) doses when compared to placebo-control group. Regarding protein expression of dystrophin, 3 J (p < 0.001) and 10 J (p < 0.05) doses also significantly showed increase compared to placebo-control group. We conclude that PBMT can mainly preserve muscle morphology and improve muscular function of mdx mice through modulation of gene and protein expression of dystrophin. Furthermore, since PBMT is a non-pharmacological treatment which does not present side effects and is easy to handle, it can be seen as a promising tool for treating Duchenne's muscular dystrophy.
Descrição
Citação
Lasers In Medical Science. London, v. 33, n. 4, p. 755-764, 2018.
Coleções